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Abstract 
Congestive heart failure is a chronic condition where the heart no longer pumps 
adequate blood and oxygen to bodily organs.  CHF is a chronic condition that affects 
millions of people on a yearly basis.  Common diseases that cause CHF are coronary 
artery disease, high blood pressure, and diabetes.  CHF patients face many compilations 
that affect their daily activities.  Along with morbidity CHF has major financial 
implications because much of the cost associated with CHF healthcare is avoidable.  The 
purpose of this study is to evaluate the effects of monitoring congestive heart failure 
across the healthcare continuum with application to the Corbin and Strauss trajectory 
model of chronic illness.  The research hypothesis is that monitoring CHF across the 
healthcare continuum effects CHF readmission rates.   
This study was conducted at a large medical university hospital. The sample size 
includes a random selection of 100 consecutive CHF admission occurrences.  
Retrospective data was reviewed using a chart audit tool.  Data included in the review 
were admission dates, discharge dates, readmission dates if applicable, disposition and, 
financial class.   Data analysis for the study was done by using a chi-squared test.  The 
dependent variables in the study were readmission in 30 days or less compared to no 
readmission in 30 days or less. The null hypothesis for the chi-squared test is there is no 
relationship between readmissions and care across the continuum.  The study failed to 
reject H0 at 5% of level of significance.  
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Chapter One 
 Introduction 
Statement of Problem 
Congestive heart failure (CHF) is a chronic, debilitating condition that affects 
millions of people annually. CHF occurs when the heart can no longer pump an adequate 
supply of blood and oxygen to support other bodily organs. Coronary artery disease, high 
blood pressure, and diabetes are common causes of CHF. Individuals with CHF face 
many complications such as difficulty breathing, interference with daily activities, and 
weight gain related to swelling (American Heart Association AHA, 2011). 
CHF has become an increasing epidemic because individuals with cardiac 
conditions are living longer due to improvements in therapeutic innovations (AHA, 
2011). There are about 5.8 million people in the United Sates who have CHF.  On 
average 670,000 people are being diagnosed with the condition every year. Although 
individuals with CHF are living longer; about one and every five people with CHF die 
within one year from the diagnosis of the condition.  CHF contributed to 282,754 deaths 
in the year 2010 (Colucci, 2011). 
Current research suggests that CHF patients are facing a shorter length of stay 
with higher readmission rates. According to Colucci (2011), the CHF patient has the 
highest risk of death one month after being discharged from the hospital. About one 
quarter of those hospitalized with CHF are readmitted with thirty days (Colucci, 2011). 
In addition to the mortality of CHF there are financial implications of the disease.  
Colucci (2011) states the cost of CHF adds up to over 39 billion dollars in health care, 
pharmaceuticals, and loss of productivity. Much of the cost associated with CHF 
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healthcare is avoidable.  Medicare beneficiaries make up the bulk of those treated with 
CHF.  According to Medicare reports approximately 18% of Medicare beneficences are 
readmitted within 30 days of discharge resulting in over $12 million dollars of avoidable 
healthcare cost (Brock, 2008). 
The Centers for Disease Control and Prevention (CDC) reports that there is no 
current cure for CHF, research suggest that managing and monitoring the disease across 
the health care continuum will decrease mortality, morbidity, and hospital readmissions 
(CDC, 2010).  Individuals with CHF need careful monitor of symptoms and conditions in 
both the outpatient and inpatient setting. 
Purpose 
The purpose of this study is to evaluate the effects of monitoring congestive heart 
failure across the healthcare continuum on readmission rates of 30 days or less utilizing 
the Corbin and Strauss trajectory model of chronic illness. 
Background 
Disease process. 
 Heart Failure (HF) occurs when the pumping action of the heart malfunctions.  
According to AHA (2011), HF is the result of diseases of the heart value or muscles, 
infection of the heart of muscle, congenital heart defects, hypertension, blocked arteries, 
and/or previously damaged heart muscles. 
There are different classes, stages and, types of heart failure dependent upon the 
symptoms and complications of the effected individual.  Systolic HF occurs when the 
lower chambers of the heart are unable to supply enough blood to supply the body’s 
needs.  Diastolic heart failure is the result of the heart not being able to take its necessary 
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rest between beats resulting in blood refluxing in the upper champers and vessels of the 
heart (Torpy, 2009). 
 The result of both diastolic and systolic HF is fluid build up or edema in the 
lungs, legs, and other parts of the body.  The excess fluid causes the heart to compensate 
by becoming hypertrophic, thickening of muscle walls, or through dilation of the 
chambers.  Complications resulting from the heart’s remodeling are weakness, fatigue, 
palpations, shortness of breath, neck vein distention, and swelling in the abdomen and 
lower extremities (Torpy, 2009). 
The American Heart Association’s New York Heart Association Functional 
(NYHA) Classification is the most commonly used model for classifying heart failure.  
The NYHA has two categories for classification: functional assessment and objective 
assessment (see Table 1). 
Table 1 
American Heart Association’s New York Heart Association Functional (NYHA) 
Classification 
Class Functional Capacity: How the cardiac disease patient feels w/ physical activity 
I Individual has cardiac disease but no limits in physical activity. 
II Individual has cardiac disease with slight limits on physical activity.  Individual 
comfortable when at rest. 
III Individual has cardiac disease with noticeable limits on physical activity.  Individual 
comfortable when at rest. Activity that is less than ordinary causes fatigue, shortness of 
breath, chest pain, or palpitations. 
IV Individuals with cardiac disease are unable to carry out physical activity without 
discomfort.  Chest pain and other symptoms may be present at rest.  Discomfort increases 
with physical activity. 
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Class Objective Assessment 
A No objective signs of cardiovascular diseases noted.  Individual has no symptoms and no 
limitation on physical activity. 
B Minimal objective evidence of disease.  Individual has mild symptoms with slight limits 
on ordinary activity. Comfortable at rest. 
C Moderately severe evidence of cardiovascular disease noted. Obvious limits of activity. 
Individual comfortable at rest. 
D Severe objective evidence of cardiovascular disease.  Individual has severe limitation with 
presence of symptoms at rest. 
Note. Adapted from the American Heart Association. 2011 
Complications from HF have major effects on an individual’s quality of life.  The 
end stage of HF results when the healthcare team has exhausted all resources in managing 
the disease or the individual refuses to comply or accept treatment.  The result of not 
being able to treat HF is death.  The two main causes of death in heart failure patients are 
sudden cardiac death and progressive pump failure (Colucci, 2011). 
Treatment. 
The National Guideline Clearinghouse (NGC) is an initiative of United States 
Department of Health and Human Services’ (DHHS) Agency for Healthcare Research 
and Quality.  The objectives of NGC are to define practices to meet the needs of the 
majority of patient populations and to aid healthcare providers in decision making by 
detailing a list of acceptable treatment options for prevention, diagnosis, and management 
of diseases such as HF. 
As with every health process diagnosis begins with assessment. When diagnosing 
the HF patient it is imperative for providers to obtain a health history, height, weight, 
body mass index, use of drugs/alcohol and, orthostatic blood pressures. Subjective matter 
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to include in the assessment is information regarding the individual’s ability to perform 
activities of daily living including any limitations.  (NGC, 2009). 
Other necessary clinical indicators for HF will be shown on a 12-lead 
electrocardiography which shows the heart’s rhythm by analyzing its electrical signals.  
X-rays are commonly used to show the front and the side chest.  Another radiography test 
is the echocardiogram (ECHO).  When an ECHO is coupled with doppler flow studies 
the test will provide a moving visual of the heart’s beat and blood flow while providing 
images of the heart’s structure and valves.  In certain populations it may be necessary to 
conduct sleep studies to determine if the patient is experiencing sleep disturbed breathing. 
(NGC, 2009). 
More comprehensive studies to diagnosis HF include a stress test and/or cardiac 
catherization.  For a stress test individuals experience the effect of stress on the heart by 
either exercising on a treadmill or through medicine induced stress.  A stress test allows 
providers to see if the heart is getting enough blood and oxygen during exercise or 
stressed activities.  Coronary arteriography is an invasive type of x-ray that shows 
blockages and plaque build up in the coronary arteries.  If indicated other test will include 
Holter monitoring which records an individual’s cardiac rhythm for 24 hours on a 
portable monitor, biopsy of cardiac tissue and / or, rheumatologic disease workup. (NGC, 
2009). 
Analyzing lab work is a crucial component of the HF diagnosis process.  A 
complete blood count is usually the initial lab draw.  The NGC (2009) recommends 
another key lab which is a B-type natriuretic peptide, brain natriuretic peptide, or simply 
BNP.  BNP is a hormone secreted by the brain that typically rises when a patient has HF.  
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BNP levels are linked with HF severity, often concluding a poorer prognosis in those 
with higher levels of BNP (Association for Clinical Chemistry, 2011). 
Although HF has no cure individuals with HF have options to manage their 
condition.  One of the most critical things the healthcare team can do is to educate 
patients on HF and therapeutic compliance.  The NGC (2009) recommends that 
individuals receive counseling on abstaining from smoking, drinking, and drugs.  The 
NGC (2009) also recommends exercise in HF patients to promote quality of life.  AHA’s 
Get with the Guidelines -Heart Failure is a collaborative quality improvement measure 
that’s has demonstrated an increased adherence to evidence based care in patients 
hospitalized with HF (AHA, 2011).  Get with the Guidelines measures supported by this 
research study include discharged calls, follow-up scheduled appointment, and disease 
management referral (AHA, 2011).   
When treating HF the NGC (2009) recommends ten different methods of 
pharmacological managements. Due to the increased body fluid diuretics commonly 
called "water pills” are the most widely used drug classification for treating HF. Diuretics 
work by helping the body excrete excess water and sodium. Vasodilators are medications 
that work by relaxing blood vessel to lower blood pressure. Because HF effects the 
pumping action of the heart, drugs such as digoxin are commonly used to help the heart 
beat more efficiently (AHA, 2011).     
Other types of medications treat HF by blocking hormones in the body.  
Angiotensin converting enzyme (ACE) inhibitors blocks hormones so that the heart 
works less with the intent of preventing disease progression. Beta-adrenergic blockers 
lower blood pressure and slow heart rate creating less stress on the heart.  Angiotensin 
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receptor blockers ARBs are prescribed to lower blood pressure which is less stress on the 
pumping action of the heart.  Aldosterone antagonists works by lowering volume through 
excreting salt and water from the body.  The combination of hydralazine and nitrates is a 
medical regimen that relaxes blood vessels to decrease work load.  Inotropes are another 
class of medication and are given intravenously or directly into the blood stream to help 
the heart beat more purposefully.  Infusion of positive inotropic drugs is recommended in 
the end stages of HF to improve heart functions by allow the heart to beat more 
purposefully. (Torpy, 2009). 
 Other treatment options for HF incorporate surgical interventions.  When 
necessary the NGC (2009) recommends coronary revascularization by placing stents in 
blocked arteries, implantable defibrillators or resynchronization pacemakers, open heart 
surgery, or heart transplant if necessary.  According to the American Heart Association 
(2011), surgery is not frequently used to treat HF unless the patient has an identifiable 
problem that can be corrected with intervention.   
Management. 
Managing HF is a complex process that requires strict conformity and compliance 
to medical regimes. It is recommended by the AHA (2011) and the America College of 
Cardiology to have multidisciplinary disease management programs in high risk HF 
patients. Observational research studies have shown healthcare provider directed disease 
management programs increase the long term prognosis of HF patients.   
 Patients with all types of chronic illnesses should be enrolled in a disease 
maintenance program.  The Heart Failure Society of America, HFSA (Lindenfeld et al., 
2010) recommends multidisciplinary HF disease management programs in high risk 
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patients. The HFSA (Lindenfeld et al., 2010) defines high risk patients as those with 
diabetes, low urine output, renal insufficiency, chronic obstructive pulmonary disease, 
persistent NYHA class III or IV symptoms, frequent hospitalizations, multiple 
comorbidities, depression or cognitive impairment, inadequate social support, poor health 
literacy, and/or persistent noncompliance with medical regimes. 
  Patients with HF are to assume a self management role while in the recovery phase 
of the disease process.  In regards to self management individuals face many questions. 
While in the hospital patients may clearly understand discharge education.  Discharge 
instructions may soon be forgotten when an individual gets home.  As concluded by 
Horwitz and Krumholz (2011) patients may not understand instruction, signs of 
worsening, or even who to call with questions.  Horwitz and Krumholz (2011) further 
emphasizes that the lack of coordination between patients and providers lead to poor 
outcomes, additional costly expenditures, and need for more health care services. 
 With disease management programs individuals have support across the continuum 
to aid in the maintenance and recovery of a chronic condition. In regards to disease 
management, Horwitz and Krumholz (2011) states such programs allow for an integrated 
multidisciplinary approach for caring for chronic illnesses. Their research by also 
supports the use of disease management programs, stating care plans provide education, 
support, and coordination among care and treatment of chronically ill individuals. 
Social Significance 
 There are significant social implications regarding HF due to the vast number of 
Americans at risk for developing the disease. Results from the 2010 Census Bureau 
(Howden & Meyer, 2011) indicate that the number of older individuals grew at a greater 
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rate than younger ages.  Howden and Meyer (2011) further state that there are 40.3 
million persons over the age of 65 living in the United States. The CDC (2010) states HF 
is the leading cause of hospitalization among individuals over the age of 65.   
 With over 47 million Medicare beneficiaries it is essential that HF patients get 
adequate care across the continuum. According to a report released in April 2009, the 
Medicare Payment Advisory Commission, stated Medicare was in charge of paying for 
all admissions based on the diagnosis regardless of whether it is an initial or readmission 
related to the initial diagnosis (Hackbarth, 2009).   
Brock (2008) considers HF to be one of the most costly conditions of hospital 
readmissions. According to Brock (2008) 18% of Medicare patients are readmitted within 
30 days of discharge with 13% of those readmissions being avoidable.  The financial 
consequences of these avoidable Medicare readmissions are $12 billion. Brock (2008) 
makes further added that readmissions are an intersection of quality, cost and, patient 
safety. 
Due to the congress mandated prospective payment system hospitals are 
reimbursed on a perspective payment system. The system provides a flat rate per ace for 
inpatient services. This payment system rewards efficient hospitals while providing lower 
performing hospitals an incentive to become more efficient (Gottlober, 2001).  Starting in 
October of 2012 the current system will use an adjustment factor to reduce 
reimbursement on preventable readmission (Federal Register, 2011). 
In addition to the financial implications of readmission it is important to consider 
the inadequate care HF patients are receiving. According to Brock (2008), patients 
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readmitted within 30 days of discharge are a probable marker for poor quality of care and 
wasteful spending. 
Conceptual Framework 
The purposed research study was applied to the Corbin and Strauss trajectory 
model for chronic illness. The Trajectory framework is derived from grounded theory. 
Grounded theory is designed to discover occurrences and their characteristics. The theory 
further discovers and uncovers conditions that effect occurrences. Grounded theory draws 
out a range of possible outcomes that may occur when actions occur or fail to occur. The 
goal of this study is to determine if monitoring HF with outpatient services will affect the 
occurrence of patients being readmitted to the hospital in thirty days or less. Validity of 
the Corbin and Strauss model is evident in the fact that research was conducted in a 
variety of conditions, illnesses, and settings (Woog, 1992). 
Concepts of the trajectory model denote the course of an illness with the 
combined efforts of the patient, family and, healthcare team. The model further shapes 
the disease process to determine outcomes, managing symptoms, and handling disability 
(see Table 2).  Lastly the model states diseases have a course of action that cannot always 
be predicted (Woog, 1992). 
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Table 2 
Corbin and Strauss Chronic Illness Trajectory Framework 
Major concepts  
 Trajectory Collaborative efforts of patient, family, 
healthcare team to shape disease course 
 Trajectory phasing Changes/ phases in the course of a chronic 
illness 
Trajectory projection Individualized vision of illness course 
Trajectory scheme  Plan to shape, control, and hand disability of an 
illness 
Note. Adapted from The Chronic Illness Trajectory Framework: the Corbin and Strauss 
Nursing Model, by P. Woog, p. 16. Copyright 1992 by Springer Publishing Company. 
 
The model further concludes chronic illnesses have a course that can be shaped 
through disease management. Most of the disease management occurs outside the 
hospital.  Healthcare providers must be able to adapt treatments to an individual’s 
lifestyle.  Providing patients with care in their own home environment allows providers to 
see limitation faced by the patient (Woog, 1992).   
Theoretical Assumptions 
The purpose study shares the same theoretical assumptions of the Corbin and 
Strauss model.  The trajectory model concluded there were eight phases in the process of 
the chronic illness.  The proposed study supports the trajectory model but considers 
cycling and repeating of phases outlined in the Corbin and Strauss model.  Table 3 
applies HF to the phases in the trajectory model.  Figure 1 was formulated to show the 
conceptual framework behind the HF disease process. 
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Table 3 
Trajectory Model Applied to Heart Failure 
Phases Definition Application to study 
Pretrajectory Asymptomatic phase prior to 
course of illness onset. 
Progression and preventive 
phase 
Disease  begins to progress in 
Individuals with HF risk 
failures such as CAD, DM, 
valve disease, HTN, and other 
morbidities 
Trajectory onset Diagnostic phase where signs 
and symptoms began to appear 
Individuals present to clinic or 
providers with unexplained 
weight gain, SOB, and activity 
intolerance  
Crisis  Life threatening  Symptoms requiring emergency 
treatment from ER or CHF 
observation unit 
Acute Active illness requiring need 
for hospitalization  
Conditions not controlled in ER 
requiring  
Stable Current medical regime is 
controlling disease process 
Stabilized HF individual can be 
discharged on current regime 
Unstable Period where disease requires 
invention but not 
hospitalization  
Interventions provided from 
discharge calls, home health 
nurse, provider at CHF clinic 
Downward Continued deterioration and 
disease progression 
Patient requiring hospital 
readmission  
Dying Immediate time preceding death Referral to hospice.  
Possible mortality. 
Note. Adapted from The Chronic Illness Trajectory Framework: the Corbin and Strauss 
Nursing Model, by P. Woog, p. 17. Copyright 1992 by Springer Publishing Company. 
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Figure1 
Conceptual Framework of Heart Failure Disease Process 
 
 
Research Hypothesis 
Ancheta (2006) states that most studies on HF use a retrospective analysis or 
predictive model. Issues with retrospective models are different demographics, 
compliance levels and, utilization of new therapies. Patients who present with HF have 
acute onset of complications that need to be addressed immediately. When an 
intervention is unsuccessful providers can look back to see what course of action should 
be utilized next.  Looking back on the success of interventions can be done on an 
individual or hospital wide basis. This retrospective research can be used to aid 
improvements in managing across the continuum in future HF populations. The research 
hypothesis is that monitoring CHF across the healthcare continuum effects CHF 
readmission rates. 
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Chapter 2 
 Literature Review 
Two electronic databases where utilized to search the literature including 
PubMED and CINAHL. The following key words were utilized to search the literature: 
congestive heart failure, CHF, heart failure, retrospective, and trajectory. A total of 15 
research studies applicable to the subject of this study were chosen for the literature 
review; these included studies related to tele-monitoring, outpatient studies, end of life 
care studies, psychosocial implications, and chart audit studies.   
Tele-monitoring Research 
  In regards to monitoring HF across the healthcare continuum tele-monitoring is 
one of the most crucial and important areas to research. Tele-monitoring allows 
healthcare providers to gain diagnostic information without the patient ever leaving their 
home. When a patient is at risk for hospitalization or has worsening symptoms the 
provider can intervene in an adequate amount of time. 
Research by Gambetta et al. (2007) indicates that tele-monitoing is an important 
part of managing HF. The purpose of the study was to present an investigation to 
determine the impact of telemarketing on HF management process. The study was a 
quantitative design that compared baseline characteristics between patients that utilized 
telemarketing alone as opposed to tele-monitoring and the support of a HF clinic. The 
sample was 282 patients who had NYHA class III or IV HF. Inclusion criteria were 
patients hospitalized twice within the past year with a diagnosis of HF.  Data collection 
was done through assessment. Assessments were completed by cardiologist, an advanced 
practice nurse and, the HF nurse team. Study participants were assessed every 1-2 weeks. 
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Participants in the tele-monitoring group were given a welcome packet with telephone 
numbers and instructions. Subjects also received a scale with a digital display. 
Information was stored and analyzed using automatic decision support tools. Alerts were 
set for absolute values and would report signs or symptoms. Abnormal scores were 
identified by HF nurses who were able to provide intervention to that patient. Participants 
were assessed for symptom management, compliance, and successfulness of medication. 
The study found that using tele-monitoring and self-directed tele-management has a high 
value when treating the HF patient.  Researchers in the study concluded that tele-
monitoring is successful in HF management but feels further works needs to be done in 
shaping HF management in general. (Gambetta et al., 2007). 
Research by Wade et al. (2011) assessed the impact of providing internet-based 
tele-monitoring to supplement nursing care. The study was a randomized clinical trial 
that compared the effects of case management. The study invited Medicare advantaged 
members with HF living in New York, New Jersey, or Pennsylvania. The groups in the 
study were tele-monitoring with case management versus tele-monitoring alone. 
Individuals in the study had a remote management unit placed in their home via secure 
internet through broadband connection. A wired blood pressure cuff, and wireless weight 
scale transmitted data to the case management team. Data was collected using the Quality 
Control Inc. SF 12 Health Survey. The study concluded despite effective implementation 
there was no discernible impact on overall morbidity or mortality. The study did conclude 
that there was a reduction in hospitalizations for trial participants. Although mortality or 
morbidity did not change, decreasing admissions provides substantial cost savings for 
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healthcare. Researchers believe had the study been longer are conducted on a larger 
population results may have been different. (Wade et al., 2011). 
Research by Copeland et al. (2010) found the benefits of using telephone 
interventions in managing HF. The purpose of the study was to assess if telephone 
intervention improved quality of life and outcomes in patients with CHF. Participants 
came from the Veteran’s Administration (VA). The study used 458 participants in a 
quantitative randomized trial. The study had one year of pre-intervention, one year of 
intervention, and a follow-up period.  Data was collected using patient self-reports, 
instructor interviews, patient electronic records, and data extraction from the VA 
Resource Allocation Center for cost estimates. Patients in the study had access to a 
round-the-clock nurse advice line, medication reminders, action plans, literature, and 
motivational interviewing sessions. The study concluded no actual survivor benefit but it 
did provide behavioral improvements for those diagnosed HF.  The study lacked 
information regarding the impact of telephone monitoring has on readmissions (Copeland 
et al., 2010) 
The previous studies show little improvement in mortality and morbidity with HF. 
The studies do conclude better quality of life, decreased hospitalization and disease 
management when utilizing tele-monitoring. Possibly providing more aggressive 
interventions and tele-monitoring early in the HF disease process would improve 
outcomes.  Researchers in the study concluded short time frames and small population 
samples are possible reasons for little to no improvements on mortality. 
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Outpatient Clinic Research 
Outpatient clinics are one of the main outlets for providing HF monitoring across 
the healthcare continuum. The use of outpatient services is vital after a patient has been 
hospitalized with HF. Outpatient clinics provide patient with the care they need to avoid 
unnecessary hospitalizations.   
Research by Proctor et al. (2000) suggests that discharge planning decreases cost 
by increasing quality of care and prevention of early readmission. The study specifically 
looks at home care and its relationship with readmission rates among Medicare patients at 
an unidentified hospital.  The study used a prospective design to track Medicare patients 
with HF after their discharge. The sample included 253 Medicare patients that were ages 
65 and older. The study had a quantitative design that gathered data from a structured 
telephone interviews. The interviews were conducted at 6 weeks, 10 weeks, and 14 weeks 
post discharge. The study found that CHF patients most likely to be readmitted were 
sicker, noncompliant and, received less than adequate home care. The study suggests 
more research needs to be done in the home setting rather then while the patient is still 
institutionalized. This study was beneficial and it can used to identify and target 
individuals who are most likely to be readmitted in the weeks post discharge (Proctor et 
al. 2000). 
A study by Muss et al. (2010) looked at Veteran Affairs (VA) in a rural area to 
determine what impact outpatient visits have on hospital readmissions. The purpose of 
the study was to identify and compare potentially preventable readmissions with usage of 
30 day post discharge services. The study used logistic regression to examine post acute 
service use and its impact on readmission rates. Data from the VA from 2005 until 2007 
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was analyzed to examine patient characteristics and hospital admission rates among 
veterans. Data from the  sample was collected, categorize, and group using the 3M 
Potentially Preventable Readmissions (PPR) software. The PPR software identifies 
readmission are that result from deficiencies in care or treatment as opposed to unrelated 
events. Any related admissions that occurred within 30 days subsequent to an admission 
were identified as a PPR.  The quantitative study concluded that post follow-up care is an 
important factor to promote recovery and good health among hospitalized individuals 
with heart failure. (Muss et al., 2010). 
Research by Freimark et al. (2009) looked at data over five years at a CHF 
daycare clinic. Data was reviewed retrospectively on all patients admitted to that Medical 
Center CHF daycare between September 2000 and September 2005. The sample included 
190 advanced CHF patients. Information for the study was gathered by reviewing the 
computerized medical records of patients participating in the CHF daycare. Data included 
in the study was mortality, disease exacerbation, hospitalizations, and/or significant 
changes in patient condition. The study concluded that it is beneficial to provide CHF 
patients with outpatient services. Outpatient services provided in the study include 
multidrug intravenous treatment, electrolyte monitoring, cardiac rhythm monitoring, 
patient education, psychological support, and monitoring of cardiac rhythm. This study 
showed a reduction in morbidity and mortality and hospitalization were deceased during 
the time of the study.  (Freimark et al., 2009) 
The previous mentioned studies concluded that outpatient care plays a key role in 
decreasing readmissions rates. It is also beneficial to identify those who are at high risk 
for hospital readmission. Those at the highest rated for readmissions need to be targeted 
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and monitored closely across the health care continuum. All patients need to be 
monitored by a multidisciplinary team; those who are at high risk for admissions need to 
be given priority and more aggressive care in the outpatient setting.   
End of Life Care Research 
Research conducted by Haydar et al. (2004) incorporated interdisciplinary weekly 
meetings to assure care coordination in end of life CHF and dementia patients. The study 
was a retrospective case controlled study that took placed in a geriatrician led 
interdisciplinary house call program.  Patients were homebound and died under the care 
of the house call program from October 1996 to April 2001. The study sample was 142 
patients with a diagnosis of CHF or dementia.  Medical records where reviewed to obtain 
patient demographic, measure of function status, hospitalizations, and death place. The 
study determined that patients with CHF were more likely to have care plans directed at 
disease modification and treatments.  According to research, patients with CHF who die 
in the hospital create twice the expense as those who die elsewhere.  (Haydar et al., 
2004). 
A research study by Seamark et al. (2002) explored the prevalence of 
symptomatic HF in order to adopt a palliative care approach.  The study was city based in 
a market town with a rural catchment area.  Participants where selected through hand 
searching which yielded 548 patients with symptomatic HF.  The study was able to 
demonstrate a pragmatic method to estimate the prevalence of HF through utilization of 
diagnostic testing such as BNP levels. Although the death rate in the cohort was lower 
than expected the study was able to develop a palliative care approach in participants who 
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die not experience sudden death.  The study suggests further studies to identify HF 
patients with dying trajectory. (Seamark et al., 2002). 
Research by Gott et al. (2007) explored dying trajectories in HF.  The study used 
a quantitative longitudinal design.  The sample had a total of 27 participated who were 
diagnosed with HF, 60 years or older who had completed questionnaires for a minimum 
of five specific time points prior to death.  The study used the Kansas City 
Cardiomyopathy Questionnaire Physical Limitation Score.  From the data collected 
researchers in this study where unable to identify a typical dying trajectory.  The 
researcher suggests their findings challenge efforts to plan a deliver palliative care based 
on a theoretical HF death trajectory. (Gott et al., 2007) 
Boyd et al., (2009) evaluated services available for people with advanced HF and 
end of life care in the United Kingdom.  The studied used longitudinal analysis of 
interview triads in addition with cross-sectional analysis of interviews at specific stages.  
Researchers were able to gain access to patient and family experiences as treatments and 
services were discussed.  Recruitment for the study wad done through a purposeful 
sampling of individuals with NYHA Class III or IV HF. Data was collected through 
serial qualities interviews with participants and their families. The study led to the 
development of a HF care framework with varying stages.  The study concluded that 
patients with long-term conditions needing palliative care should be identified and 
managed proactively using pragmatic criteria.  (Boyd et al., 2009) 
Research by Gott et al. (2007) supports that of Seamark et al. (2002) in that dying 
trajectories are not always predictable.   The research suggests proactive approaches to 
managing dying trajectories.  
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Psychosocial Implications 
The Worcester Heart Failure Study conducted by Saczynski et al., (2009) used a 
life table analysis to examine the difference in long term survival in relation to age. The 
study examined age specific differences in clinical presentation, receipt of therapy, 
recommended lifestyle modification and survival in hospitalized patients with acute heart 
failure. The study was a qualitative population based study conducted in a large Central 
New England metropolitan hospital.  The study had 4534 patients and conducted 
observational research between 1995 and 2000. Medical records were reviewed for 
demographic, clinical and treatment data.  Research participants were divided in four age 
groups; below age 65, ages 65-74, ages 74-84 and above 85. The study concluded that 
patients age 75 and older were mostly likely female, with multiple comorbidities, lower 
body mass index and higher ejection fractions. The study also concluded that older 
patients were more likely to receive symptom modifying medication as apposed to 
disease modifying treatments. The study contributes great knowledge to research in that 
older patient respect a distinct clinical presentation. (Saczynski et al., 2009). 
A research study by Dejong et al. (2005) supports the importance of assessing and 
treating patients with psychosocial parameters.  The purpose of the study was to consider 
the impact of sociodemographic, clinical, health perception and, emotional variables in 
predicting health status. The study tested a multivariable model of health status and was a 
sub study of a prospective, randomized clinical trail designed to determine the optimal 
disease management regimen to improve outcomes in HF patients. The study used 87 
participants to conceptualize health related quality of life, physical activity level and 
burden of symptoms. The study was conducted in three urban and suburban community 
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hospitals located in the Midwest. Participants for the study were recruited at the end of a 
HF hospitalization. The study used the Minnesota Living with Heart Failure 
Questionnaire in order to conceptualized symptoms. Questionnaires where administered 
within one week of discharge by a nurse research assistant.  Findings of the study 
concludes that clinicians who want to deliver patient center care must address 
sociodemographic and clinical measures to improve outcomes.  In addition to assessing 
these variables providers need to offer intervention to correct issues. (Dejong et al., 2005) 
In order to provide adequate patient care providers need to consider every factor 
in the treatment and diagnosis process.  Both age and social demographic play roles in 
how the HF patient is able to adapt to treatment.  Patient centered care is necessary across 
the healthcare continuum in order to improve outcomes. 
Conducting Chart Audits 
Maddocks et al. (2010) conducted a study to determine the feasibility of using 
electronic medical record (EMR) data from the Deliver Primary Healthcare Information 
(DELPHI) database.  Data was extracted in order to measure quality of care in patients 
with HF in ten primary healthcare practices in southwestern Ontario.  Researchers 
extracted data from the medical records of 488 patients who have CHF marked in the 
medical record over a period of three years. The study showed low frequencies of 
documented care items for CHF. In order to avoid errors made in the Maddocks et 
al.,(2010) study researchers should be mindful of obstacles such as incomplete patient 
records, inaccessibility of data and, reliability of EMR versus manual chart audits. 
Assiri (2011) conducted a qualitative retrospective cohort to investigate the 
clinical and therapeutic profiles of HF patients admitted to a Saudi Arabia Hospital.  The 
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study sample included 300 consecutive patients admitted to Aseer Central Hospital with a 
diagnosis of HF from June 2007 until May 2009.  Patient related data was analyzed 
utilizing frequencies, percentages, and measures of central tendencies. Results form the 
study support the concept of demonstrating trends in medical data. The study concluded 
making such data widely available will aid in the improvement of HF management and 
encourage providers to use evidence base guidelines in daily practice. 
Sanborn et al. (2005) used data from a chart audit to determine if CHF was the 
second leading cause of hospitalization in a small rural hospital. The study found that the 
majority of the patient population were older and noncompliant to prescribed medical 
regime.  The study used a chart abstraction tool to examine the care of all CHF patients 
admitted to the facility between 2000 and 2001.  The tool provided researchers with other 
information including sociodemographic status and outpatient appointment schedule.  
The study concluded CHF management in the rural area needed improvement. The study 
prompted attention to address the lack in continuity of care, outpatient services and 
access to diagnostic testing. 
The studies in this section all conclude that chart audits are valuable tools in 
obtaining data about a specific population.  When conducting chart audits researcher 
must be careful and make sure they get the whole picture so that the data is not 
misinterpreted. 
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Chapter Three 
 Methodology 
The purpose of this study is to evaluate the effects of monitoring congestive heart 
failure across the healthcare continuum with application to the Corbin and Strauss 
trajectory model of chronic illness.  This chapter describes the methodology used in the 
study including research design, sample, data collection, and data analysis.  
Procedures 
Initial approval for the study to evaluate the effects of monitoring congestive heart 
failure across the healthcare continuum on patient readmission with 30 days or less was 
obtained from the CHF Coordinator at the site where the research was conducted.  The 
following people at the site were notified of the study: The Director of Nursing for 
Cardiovascular Services, The Director of Nursing Research and the Nursing Research 
Council. The study is a retrospective chart review that used electronic medical record 
data queries to identify a sample of 100 admission cases.  
Ethical Considerations 
Prior to data collection the research study to evaluate the effects of monitoring 
congestive heart failure across the healthcare continuum on patient readmission with 30 
days or less was approved by the Institutional Research Board at Gardner-Webb 
University and by the Research Board at the study hospital. The study hospital follows 
the guidelines for patient confidentiality mandated by the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA). Confidentiality was maintained at all times 
and anonymity was insured. All account numbers, medical record numbers, and subject 
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names were omitted from the data queries. The individual records were labeled as a1 
through a100. 
Sample 
This study was conducted at a large medical university hospital. The CHF 
Coordinator of the research site has data on subjects with readmissions from the years 
2006 till present. Research subjects were admitted to an adult inpatient unit at the 
research site with an ICD-9 diagnosis relating to HF. The sample size includes a random 
selection of 100 consecutive CHF admission occurrences from the available data. 
Instruments 
A medical record audit for was used to collect data for the study. Validity of the 
audit form is evident by integrating concepts from Duke University Medical Center’s 
Department of Community and Family Medicine in its development (2005).  Variables 
addressed in the audits include, financial glass group, thirty day readmission occurrences, 
and discharge dispositions (Appendix C).  
Data Collection and Analysis 
Data queries where conducted on patients with heart failure ICD-9 codes.  
Retrospective data was reviewed from the dates of November 2009 until and May 2010.  
Data included in the review were admission dates, discharge dates, readmission dates if 
applicable, disposition and, financial class.  
Each of one of the 100 admission cases was applied to the chart audit form.  Data 
from the chart audits where compiled into corresponding groups. Occurrences and trends 
were identified.  A chi-square test was used to show the likelihood of readmission 
occurring without the intervention of monitoring across the healthcare continuum. 
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Chapter 4 
 Results 
This chapter presents the results of the study to evaluate the effects of monitoring 
CHF across the healthcare continuum.  The sample demographics are presented, followed 
by the results for the research questions. One hundred consecutive CHF admissions were 
randomly selected for the research study. A chi-square analysis of the research data was 
conducted on the patient data related to the 100 different admission occurrences. 
Demographical data collected in the study shows the financial classification 
regarding pay for services for the sample population.  The majority of subjects (79%) of 
the sample were Medicare Beneficiaries, with 10% charity cases, 7% managed care and 
only 1% private insurance.  The financial classifications regarding pay for services for the 
sample is illustrated in Figure 2.  With such a large Medicare patient population it is 
essential that care is managed correctly. According to the Unites States Department of 
Health and Human Service, Medicare will pay for inpatient acute care services based on 
care quality and not the quantity (USDA, 2011).  Research suggests patients that continue 
to get readmitted have received inadequate care somewhere in their disease management 
process. 
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Figure 2 
Financial Class Percentages 
 
 
 
 
 
 
 
 
Research has shown that readmissions are where quality, cost, and patient safety 
intersect (Brock, 2008).  Descriptive statistical analysis of the data found that a large 
portion (n =29) of the sample was readmitted in 30 days or less following discharge.  
Figure 3 illustrates the readmission rates for the sample.   
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Further breakdown of the data found over half (n =52 ) of the sample population 
was readmitted within 90 days following discharge.  Less than 20 CHF patients remained 
out of the hospitalized for a minimum of 180 days. 
Figure 4 
Readmission Rates Breakdown 
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Statistical analysis utilizing the chi-squared test was conducted to test the 
hypothesis that monitoring CHF across the healthcare continuum effects CHF 
readmission rates.  The dependent variables in the study were readmission in 30 days or 
less and no readmission in 30 days or less. The chi-squared test is used to determine how 
well observed data fits anticipated outcomes.  In this study a chi-squared test was used to 
determine the difference between the observed outcome of readmission in 30 days or less 
and the outcome that the readmission in 30 days or less was likely to occur by chance.  
The study compares what would have occurred in the absence of any true association 
between healthcare given across the continuum and ≤30 day readmission rates.  
If there is no relationship between care across the continuum and readmission in 
30 days or less it would be expected that a patient would be readmitted solely by chance. 
The null hypothesis for this study was there is no relationship between care across the 
 29 
continuum and readmission in 30 days or less for patients with CHF. The statistical level 
of significance was set at .05. Results of the chi-squared test (p=0.7276) indicated the 
results were not significant and the null hypothesis could not be rejected. The data used in 
the study was unable to establish that health care across the continuum has an effect on 
CHF patients being readmitted to the hospital in 30 days or less.  Table 4 shows the result 
of the Chi-Squared Test for Heart Failure Readmission.  
Table 4. 
Chi-Squared Test: Heart Failure Readmissions 
Chi-Squared Test: Monitoring Healthcare Across the Continuum 
Observed Outcomes 
 
Readmitted ≤30 
Days Not Readmitted in ≤30 Days 
Row 
Total
s 
Continuum Services Utilized 14 37 51 
Continuum Services Not Utilized 15 34 49 
Column Totals 29 71 100 
    
    
Expected Outcomes 
 
Readmitted ≤30 
Days Not Readmitted in ≤30 Days 
Row 
Total
s 
Continuum Services Utilized 14.79 36.21 51 
Continuum Services Not Utilized 14.21 34.79 49 
Column Totals 29 71 100 
    
    
p=value: 0.727637589   
 
 30 
Chapter Five 
Discussion 
Significance of the Findings 
The chi-squared analysis of the data did not support the hypothesis that health 
care across the continuum has an effect on CHF patients being readmitted to the hospital 
in 30 days or less. The null hypothesis could not be rejected at the 0.05 level of 
significance. The research study does provide insight on healthcare and readmission rates 
for the CHF population. The Corbin and Strauss trajectory model for chronic illness was 
suitable in the study due to the large portion of readmission occurrences for patients with 
CHF. The patients with CHF who were subjects in this study cycled and repeated phases 
in the model. Although results from the study are that readmissions occurred by chance 
and not as a result of healthcare across the continuum, it was evident that a large portion 
of the sample was readmitted in 90 days or less.   
Significance to Nursing 
There are many nursing implications to consider when dealing with the CHF 
patient.  According to Brock (2008) a quarter of all patients hospitalized with CHF are 
readmitted within 30 days.  Proper patient education, compliance promotion, and 
transition care are beneficial to patient outcomes and readmission rates. 
According to Brock (2008) 20% of Medicare beneficiaries are readmitted within 
30 days.  Brock (2008) further states the high level of readmission indicates inappropriate 
transition care, lower patient satisfaction, and increased health care cost. The high 
number of Medicare patients in this sample and the high number of readmissions calls for 
specific interventions aimed at this population of healthcare recipients. 
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There are many implications for nurses when dealing with the HF patients.  
Equipping patient with medication, scales, and blood pressure cuffs is not enough. A 
patient that monitors and medicates themselves inappropriately is an insignificant act that 
provides no benefit to the patient. According to Brock (2008) patients need to have scales 
big enough to stand on and have numbers that are visible to the patient. Missing any key 
component in the medical regime is s sign of inadequate care coordination, mismanaged 
self-care and, can lead to an unnecessary hospitalization. (Brock, 2008). The high number 
of readmissions revealed in the data analysis calls for stronger medical regime and 
management of CHF patients over the continuum of healthcare. 
In addition to patient accountably there must be accountability among providers.  
The Medicare Payment Advisory Commission states that readmissions are not a result of 
mistakes that occur in the hospital by inadequate transition preparation (Hackbarth, 
2009).  According to Brock (2008) one in five patients discharged from a hospital 
experience an adverse event within three weeks of being discharged. Injuries resulting 
from these adverse events are medicine related and often can be mitigated or avoided.  
Implications for Nursing Practice 
The study uncovered a large number of readmissions that occurred 30 days or less 
from discharge.  For nursing this is a travesty that demonstrates inadequate healthcare 
over the continuum. Nurses can be a proponent of these patients through more effective 
discharge planning, community follow up and referrals for CHF patients. Adequate 
intervention could have deferred and possibly avoided these readmissions. 
The number of readmissions also has an effect on reimbursement of services.  The 
number of charity patients in the study sample calls for decreasing readmissions. The 
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smallest percentage of decrease in hospital readmissions has the potential to decrease 
healthcare costs for all.  
Recommendations for future research 
The sample selection only included a small portion of CHF admission 
occurrences.  Future research should include a larger sample size from multiple 
healthcare facilities.  Conducting a more comprehensive analysis of discharge disposition 
could provide more insight on what continuum services are most effective. Identification 
of the relationship of financial classification regarding pay for services on readmission 
rates should be included in future research.  In order to improve outcomes and 
reimbursement, the healthcare team should analyzes which needs of the CHF patients are 
continuing to be left unmet. 
 
` 
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 Appendix B 
Medical Record Audit Instrument Developed for Study 
Date: 
Auditor: 
Admission dates included in study: 
Total Medical Records Reviewed: 
Subjects included in the audit:  
 
Financial Class Group Yes or No (Binary, only one applicable) 
Charity  
Managed Care  
Medicaid  
Medicare  
Private Insurance  
Other  
 
Discharge Status Yes or No (Binary, only one applicable) 
AMA  
Home w/o continuum services  
Home w/ CHF Clinic Visit  
Home Health  
Hospice  
SNF  
Rehab  
 
Thirty Day Readmission Occurrences Yes or No (Binary, only one applicable) 
≤30 Days  
>30 Days  
 
Readmission Occurrence Breakdown Yes or No (Binary, only one applicable) 
<30 Days  
30-59 Days  
60-89 Days  
90-119 Days  
120-149 Days  
150-179 Days  
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Abstract 
Congestive heart failure is a chronic condition where the heart no longer pumps 
adequate blood and oxygen to bodily organs.  CHF is a chronic condition that affects 
millions of people on a yearly basis.  Common diseases that cause CHF are coronary 
artery disease, high blood pressure, and diabetes.  CHF patients face many compilations 
that affect their daily activities.  Along with morbidity CHF has major financial 
implications because much of the cost associated with CHF healthcare is avoidable.  The 
purpose of this study is to evaluate the effects of monitoring congestive heart failure 
across the healthcare continuum with application to the Corbin and Strauss trajectory 
model of chronic illness.  The research hypothesis is that monitoring CHF across the 
healthcare continuum effects CHF readmission rates.   
This study was conducted at a large medical university hospital. The sample size 
includes a random selection of 100 consecutive CHF admission occurrences.  
Retrospective data was reviewed using a chart audit tool.  Data included in the review 
were admission dates, discharge dates, readmission dates if applicable, disposition and, 
financial class.   Data analysis for the study was done by using a chi-squared test.  The 
dependent variables in the study were readmission in 30 days or less compared to no 
readmission in 30 days or less. The null hypothesis for the chi-squared test is there is no 
relationship between readmissions and care across the continuum.  The study failed to 
reject H0 at 5% of level of significance.  
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Chapter One 
 Introduction 
Statement of Problem 
Congestive heart failure (CHF) is a chronic, debilitating condition that affects 
millions of people annually. CHF occurs when the heart can no longer pump an adequate 
supply of blood and oxygen to support other bodily organs. Coronary artery disease, high 
blood pressure, and diabetes are common causes of CHF. Individuals with CHF face 
many complications such as difficulty breathing, interference with daily activities, and 
weight gain related to swelling (American Heart Association AHA, 2011). 
CHF has become an increasing epidemic because individuals with cardiac 
conditions are living longer due to improvements in therapeutic innovations (AHA, 
2011). There are about 5.8 million people in the United Sates who have CHF.  On 
average 670,000 people are being diagnosed with the condition every year. Although 
individuals with CHF are living longer; about one and every five people with CHF die 
within one year from the diagnosis of the condition.  CHF contributed to 282,754 deaths 
in the year 2010 (Colucci, 2011). 
Current research suggests that CHF patients are facing a shorter length of stay 
with higher readmission rates. According to Colucci (2011), the CHF patient has the 
highest risk of death one month after being discharged from the hospital. About one 
quarter of those hospitalized with CHF are readmitted with thirty days (Colucci, 2011). 
In addition to the mortality of CHF there are financial implications of the disease.  
Colucci (2011) states the cost of CHF adds up to over 39 billion dollars in health care, 
pharmaceuticals, and loss of productivity. Much of the cost associated with CHF 
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healthcare is avoidable.  Medicare beneficiaries make up the bulk of those treated with 
CHF.  According to Medicare reports approximately 18% of Medicare beneficences are 
readmitted within 30 days of discharge resulting in over $12 million dollars of avoidable 
healthcare cost (Brock, 2008). 
The Centers for Disease Control and Prevention (CDC) reports that there is no 
current cure for CHF, research suggest that managing and monitoring the disease across 
the health care continuum will decrease mortality, morbidity, and hospital readmissions 
(CDC, 2010).  Individuals with CHF need careful monitor of symptoms and conditions in 
both the outpatient and inpatient setting. 
Purpose 
The purpose of this study is to evaluate the effects of monitoring congestive heart 
failure across the healthcare continuum on readmission rates of 30 days or less utilizing 
the Corbin and Strauss trajectory model of chronic illness. 
Background 
Disease process. 
 Heart Failure (HF) occurs when the pumping action of the heart malfunctions.  
According to AHA (2011), HF is the result of diseases of the heart value or muscles, 
infection of the heart of muscle, congenital heart defects, hypertension, blocked arteries, 
and/or previously damaged heart muscles. 
There are different classes, stages and, types of heart failure dependent upon the 
symptoms and complications of the effected individual.  Systolic HF occurs when the 
lower chambers of the heart are unable to supply enough blood to supply the body’s 
needs.  Diastolic heart failure is the result of the heart not being able to take its necessary 
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rest between beats resulting in blood refluxing in the upper champers and vessels of the 
heart (Torpy, 2009). 
 The result of both diastolic and systolic HF is fluid build up or edema in the 
lungs, legs, and other parts of the body.  The excess fluid causes the heart to compensate 
by becoming hypertrophic, thickening of muscle walls, or through dilation of the 
chambers.  Complications resulting from the heart’s remodeling are weakness, fatigue, 
palpations, shortness of breath, neck vein distention, and swelling in the abdomen and 
lower extremities (Torpy, 2009). 
The American Heart Association’s New York Heart Association Functional 
(NYHA) Classification is the most commonly used model for classifying heart failure.  
The NYHA has two categories for classification: functional assessment and objective 
assessment (see Table 1). 
Table 1 
American Heart Association’s New York Heart Association Functional (NYHA) 
Classification 
Class Functional Capacity: How the cardiac disease patient feels w/ physical activity 
I Individual has cardiac disease but no limits in physical activity. 
II Individual has cardiac disease with slight limits on physical activity.  Individual 
comfortable when at rest. 
III Individual has cardiac disease with noticeable limits on physical activity.  Individual 
comfortable when at rest. Activity that is less than ordinary causes fatigue, shortness of 
breath, chest pain, or palpitations. 
IV Individuals with cardiac disease are unable to carry out physical activity without 
discomfort.  Chest pain and other symptoms may be present at rest.  Discomfort increases 
with physical activity. 
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Class Objective Assessment 
A No objective signs of cardiovascular diseases noted.  Individual has no symptoms and no 
limitation on physical activity. 
B Minimal objective evidence of disease.  Individual has mild symptoms with slight limits 
on ordinary activity. Comfortable at rest. 
C Moderately severe evidence of cardiovascular disease noted. Obvious limits of activity. 
Individual comfortable at rest. 
D Severe objective evidence of cardiovascular disease.  Individual has severe limitation with 
presence of symptoms at rest. 
Note. Adapted from the American Heart Association. 2011 
Complications from HF have major effects on an individual’s quality of life.  The 
end stage of HF results when the healthcare team has exhausted all resources in managing 
the disease or the individual refuses to comply or accept treatment.  The result of not 
being able to treat HF is death.  The two main causes of death in heart failure patients are 
sudden cardiac death and progressive pump failure (Colucci, 2011). 
Treatment. 
The National Guideline Clearinghouse (NGC) is an initiative of United States 
Department of Health and Human Services’ (DHHS) Agency for Healthcare Research 
and Quality.  The objectives of NGC are to define practices to meet the needs of the 
majority of patient populations and to aid healthcare providers in decision making by 
detailing a list of acceptable treatment options for prevention, diagnosis, and management 
of diseases such as HF. 
As with every health process diagnosis begins with assessment. When diagnosing 
the HF patient it is imperative for providers to obtain a health history, height, weight, 
body mass index, use of drugs/alcohol and, orthostatic blood pressures. Subjective matter 
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to include in the assessment is information regarding the individual’s ability to perform 
activities of daily living including any limitations.  (NGC, 2009). 
Other necessary clinical indicators for HF will be shown on a 12-lead 
electrocardiography which shows the heart’s rhythm by analyzing its electrical signals.  
X-rays are commonly used to show the front and the side chest.  Another radiography test 
is the echocardiogram (ECHO).  When an ECHO is coupled with doppler flow studies 
the test will provide a moving visual of the heart’s beat and blood flow while providing 
images of the heart’s structure and valves.  In certain populations it may be necessary to 
conduct sleep studies to determine if the patient is experiencing sleep disturbed breathing. 
(NGC, 2009). 
More comprehensive studies to diagnosis HF include a stress test and/or cardiac 
catherization.  For a stress test individuals experience the effect of stress on the heart by 
either exercising on a treadmill or through medicine induced stress.  A stress test allows 
providers to see if the heart is getting enough blood and oxygen during exercise or 
stressed activities.  Coronary arteriography is an invasive type of x-ray that shows 
blockages and plaque build up in the coronary arteries.  If indicated other test will include 
Holter monitoring which records an individual’s cardiac rhythm for 24 hours on a 
portable monitor, biopsy of cardiac tissue and / or, rheumatologic disease workup. (NGC, 
2009). 
Analyzing lab work is a crucial component of the HF diagnosis process.  A 
complete blood count is usually the initial lab draw.  The NGC (2009) recommends 
another key lab which is a B-type natriuretic peptide, brain natriuretic peptide, or simply 
BNP.  BNP is a hormone secreted by the brain that typically rises when a patient has HF.  
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BNP levels are linked with HF severity, often concluding a poorer prognosis in those 
with higher levels of BNP (Association for Clinical Chemistry, 2011). 
Although HF has no cure individuals with HF have options to manage their 
condition.  One of the most critical things the healthcare team can do is to educate 
patients on HF and therapeutic compliance.  The NGC (2009) recommends that 
individuals receive counseling on abstaining from smoking, drinking, and drugs.  The 
NGC (2009) also recommends exercise in HF patients to promote quality of life.  AHA’s 
Get with the Guidelines -Heart Failure is a collaborative quality improvement measure 
that’s has demonstrated an increased adherence to evidence based care in patients 
hospitalized with HF (AHA, 2011).  Get with the Guidelines measures supported by this 
research study include discharged calls, follow-up scheduled appointment, and disease 
management referral (AHA, 2011).   
When treating HF the NGC (2009) recommends ten different methods of 
pharmacological managements. Due to the increased body fluid diuretics commonly 
called "water pills” are the most widely used drug classification for treating HF. Diuretics 
work by helping the body excrete excess water and sodium. Vasodilators are medications 
that work by relaxing blood vessel to lower blood pressure. Because HF effects the 
pumping action of the heart, drugs such as digoxin are commonly used to help the heart 
beat more efficiently (AHA, 2011).     
Other types of medications treat HF by blocking hormones in the body.  
Angiotensin converting enzyme (ACE) inhibitors blocks hormones so that the heart 
works less with the intent of preventing disease progression. Beta-adrenergic blockers 
lower blood pressure and slow heart rate creating less stress on the heart.  Angiotensin 
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receptor blockers ARBs are prescribed to lower blood pressure which is less stress on the 
pumping action of the heart.  Aldosterone antagonists works by lowering volume through 
excreting salt and water from the body.  The combination of hydralazine and nitrates is a 
medical regimen that relaxes blood vessels to decrease work load.  Inotropes are another 
class of medication and are given intravenously or directly into the blood stream to help 
the heart beat more purposefully.  Infusion of positive inotropic drugs is recommended in 
the end stages of HF to improve heart functions by allow the heart to beat more 
purposefully. (Torpy, 2009). 
 Other treatment options for HF incorporate surgical interventions.  When 
necessary the NGC (2009) recommends coronary revascularization by placing stents in 
blocked arteries, implantable defibrillators or resynchronization pacemakers, open heart 
surgery, or heart transplant if necessary.  According to the American Heart Association 
(2011), surgery is not frequently used to treat HF unless the patient has an identifiable 
problem that can be corrected with intervention.   
Management. 
Managing HF is a complex process that requires strict conformity and compliance 
to medical regimes. It is recommended by the AHA (2011) and the America College of 
Cardiology to have multidisciplinary disease management programs in high risk HF 
patients. Observational research studies have shown healthcare provider directed disease 
management programs increase the long term prognosis of HF patients.   
 Patients with all types of chronic illnesses should be enrolled in a disease 
maintenance program.  The Heart Failure Society of America, HFSA (Lindenfeld et al., 
2010) recommends multidisciplinary HF disease management programs in high risk 
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patients. The HFSA (Lindenfeld et al., 2010) defines high risk patients as those with 
diabetes, low urine output, renal insufficiency, chronic obstructive pulmonary disease, 
persistent NYHA class III or IV symptoms, frequent hospitalizations, multiple 
comorbidities, depression or cognitive impairment, inadequate social support, poor health 
literacy, and/or persistent noncompliance with medical regimes. 
  Patients with HF are to assume a self management role while in the recovery phase 
of the disease process.  In regards to self management individuals face many questions. 
While in the hospital patients may clearly understand discharge education.  Discharge 
instructions may soon be forgotten when an individual gets home.  As concluded by 
Horwitz and Krumholz (2011) patients may not understand instruction, signs of 
worsening, or even who to call with questions.  Horwitz and Krumholz (2011) further 
emphasizes that the lack of coordination between patients and providers lead to poor 
outcomes, additional costly expenditures, and need for more health care services. 
 With disease management programs individuals have support across the continuum 
to aid in the maintenance and recovery of a chronic condition. In regards to disease 
management, Horwitz and Krumholz (2011) states such programs allow for an integrated 
multidisciplinary approach for caring for chronic illnesses. Their research by also 
supports the use of disease management programs, stating care plans provide education, 
support, and coordination among care and treatment of chronically ill individuals. 
Social Significance 
 There are significant social implications regarding HF due to the vast number of 
Americans at risk for developing the disease. Results from the 2010 Census Bureau 
(Howden & Meyer, 2011) indicate that the number of older individuals grew at a greater 
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rate than younger ages.  Howden and Meyer (2011) further state that there are 40.3 
million persons over the age of 65 living in the United States. The CDC (2010) states HF 
is the leading cause of hospitalization among individuals over the age of 65.   
 With over 47 million Medicare beneficiaries it is essential that HF patients get 
adequate care across the continuum. According to a report released in April 2009, the 
Medicare Payment Advisory Commission, stated Medicare was in charge of paying for 
all admissions based on the diagnosis regardless of whether it is an initial or readmission 
related to the initial diagnosis (Hackbarth, 2009).   
Brock (2008) considers HF to be one of the most costly conditions of hospital 
readmissions. According to Brock (2008) 18% of Medicare patients are readmitted within 
30 days of discharge with 13% of those readmissions being avoidable.  The financial 
consequences of these avoidable Medicare readmissions are $12 billion. Brock (2008) 
makes further added that readmissions are an intersection of quality, cost and, patient 
safety. 
Due to the congress mandated prospective payment system hospitals are 
reimbursed on a perspective payment system. The system provides a flat rate per ace for 
inpatient services. This payment system rewards efficient hospitals while providing lower 
performing hospitals an incentive to become more efficient (Gottlober, 2001).  Starting in 
October of 2012 the current system will use an adjustment factor to reduce 
reimbursement on preventable readmission (Federal Register, 2011). 
In addition to the financial implications of readmission it is important to consider 
the inadequate care HF patients are receiving. According to Brock (2008), patients 
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readmitted within 30 days of discharge are a probable marker for poor quality of care and 
wasteful spending. 
Conceptual Framework 
The purposed research study was applied to the Corbin and Strauss trajectory 
model for chronic illness. The Trajectory framework is derived from grounded theory. 
Grounded theory is designed to discover occurrences and their characteristics. The theory 
further discovers and uncovers conditions that effect occurrences. Grounded theory draws 
out a range of possible outcomes that may occur when actions occur or fail to occur. The 
goal of this study is to determine if monitoring HF with outpatient services will affect the 
occurrence of patients being readmitted to the hospital in thirty days or less. Validity of 
the Corbin and Strauss model is evident in the fact that research was conducted in a 
variety of conditions, illnesses, and settings (Woog, 1992). 
Concepts of the trajectory model denote the course of an illness with the 
combined efforts of the patient, family and, healthcare team. The model further shapes 
the disease process to determine outcomes, managing symptoms, and handling disability 
(see Table 2).  Lastly the model states diseases have a course of action that cannot always 
be predicted (Woog, 1992). 
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Table 2 
Corbin and Strauss Chronic Illness Trajectory Framework 
Major concepts  
 Trajectory Collaborative efforts of patient, family, 
healthcare team to shape disease course 
 Trajectory phasing Changes/ phases in the course of a chronic 
illness 
Trajectory projection Individualized vision of illness course 
Trajectory scheme  Plan to shape, control, and hand disability of an 
illness 
Note. Adapted from The Chronic Illness Trajectory Framework: the Corbin and Strauss 
Nursing Model, by P. Woog, p. 16. Copyright 1992 by Springer Publishing Company. 
 
The model further concludes chronic illnesses have a course that can be shaped 
through disease management. Most of the disease management occurs outside the 
hospital.  Healthcare providers must be able to adapt treatments to an individual’s 
lifestyle.  Providing patients with care in their own home environment allows providers to 
see limitation faced by the patient (Woog, 1992).   
Theoretical Assumptions 
The purpose study shares the same theoretical assumptions of the Corbin and 
Strauss model.  The trajectory model concluded there were eight phases in the process of 
the chronic illness.  The proposed study supports the trajectory model but considers 
cycling and repeating of phases outlined in the Corbin and Strauss model.  Table 3 
applies HF to the phases in the trajectory model.  Figure 1 was formulated to show the 
conceptual framework behind the HF disease process. 
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Table 3 
Trajectory Model Applied to Heart Failure 
Phases Definition Application to study 
Pretrajectory Asymptomatic phase prior to 
course of illness onset. 
Progression and preventive 
phase 
Disease  begins to progress in 
Individuals with HF risk 
failures such as CAD, DM, 
valve disease, HTN, and other 
morbidities 
Trajectory onset Diagnostic phase where signs 
and symptoms began to appear 
Individuals present to clinic or 
providers with unexplained 
weight gain, SOB, and activity 
intolerance  
Crisis  Life threatening  Symptoms requiring emergency 
treatment from ER or CHF 
observation unit 
Acute Active illness requiring need 
for hospitalization  
Conditions not controlled in ER 
requiring  
Stable Current medical regime is 
controlling disease process 
Stabilized HF individual can be 
discharged on current regime 
Unstable Period where disease requires 
invention but not 
hospitalization  
Interventions provided from 
discharge calls, home health 
nurse, provider at CHF clinic 
Downward Continued deterioration and 
disease progression 
Patient requiring hospital 
readmission  
Dying Immediate time preceding death Referral to hospice.  
Possible mortality. 
Note. Adapted from The Chronic Illness Trajectory Framework: the Corbin and Strauss 
Nursing Model, by P. Woog, p. 17. Copyright 1992 by Springer Publishing Company. 
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Figure1 
Conceptual Framework of Heart Failure Disease Process 
 
 
Research Hypothesis 
Ancheta (2006) states that most studies on HF use a retrospective analysis or 
predictive model. Issues with retrospective models are different demographics, 
compliance levels and, utilization of new therapies. Patients who present with HF have 
acute onset of complications that need to be addressed immediately. When an 
intervention is unsuccessful providers can look back to see what course of action should 
be utilized next.  Looking back on the success of interventions can be done on an 
individual or hospital wide basis. This retrospective research can be used to aid 
improvements in managing across the continuum in future HF populations. The research 
hypothesis is that monitoring CHF across the healthcare continuum effects CHF 
readmission rates. 
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Chapter 2 
 Literature Review 
Two electronic databases where utilized to search the literature including 
PubMED and CINAHL. The following key words were utilized to search the literature: 
congestive heart failure, CHF, heart failure, retrospective, and trajectory. A total of 15 
research studies applicable to the subject of this study were chosen for the literature 
review; these included studies related to tele-monitoring, outpatient studies, end of life 
care studies, psychosocial implications, and chart audit studies.   
Tele-monitoring Research 
  In regards to monitoring HF across the healthcare continuum tele-monitoring is 
one of the most crucial and important areas to research. Tele-monitoring allows 
healthcare providers to gain diagnostic information without the patient ever leaving their 
home. When a patient is at risk for hospitalization or has worsening symptoms the 
provider can intervene in an adequate amount of time. 
Research by Gambetta et al. (2007) indicates that tele-monitoing is an important 
part of managing HF. The purpose of the study was to present an investigation to 
determine the impact of telemarketing on HF management process. The study was a 
quantitative design that compared baseline characteristics between patients that utilized 
telemarketing alone as opposed to tele-monitoring and the support of a HF clinic. The 
sample was 282 patients who had NYHA class III or IV HF. Inclusion criteria were 
patients hospitalized twice within the past year with a diagnosis of HF.  Data collection 
was done through assessment. Assessments were completed by cardiologist, an advanced 
practice nurse and, the HF nurse team. Study participants were assessed every 1-2 weeks. 
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Participants in the tele-monitoring group were given a welcome packet with telephone 
numbers and instructions. Subjects also received a scale with a digital display. 
Information was stored and analyzed using automatic decision support tools. Alerts were 
set for absolute values and would report signs or symptoms. Abnormal scores were 
identified by HF nurses who were able to provide intervention to that patient. Participants 
were assessed for symptom management, compliance, and successfulness of medication. 
The study found that using tele-monitoring and self-directed tele-management has a high 
value when treating the HF patient.  Researchers in the study concluded that tele-
monitoring is successful in HF management but feels further works needs to be done in 
shaping HF management in general. (Gambetta et al., 2007). 
Research by Wade et al. (2011) assessed the impact of providing internet-based 
tele-monitoring to supplement nursing care. The study was a randomized clinical trial 
that compared the effects of case management. The study invited Medicare advantaged 
members with HF living in New York, New Jersey, or Pennsylvania. The groups in the 
study were tele-monitoring with case management versus tele-monitoring alone. 
Individuals in the study had a remote management unit placed in their home via secure 
internet through broadband connection. A wired blood pressure cuff, and wireless weight 
scale transmitted data to the case management team. Data was collected using the Quality 
Control Inc. SF 12 Health Survey. The study concluded despite effective implementation 
there was no discernible impact on overall morbidity or mortality. The study did conclude 
that there was a reduction in hospitalizations for trial participants. Although mortality or 
morbidity did not change, decreasing admissions provides substantial cost savings for 
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healthcare. Researchers believe had the study been longer are conducted on a larger 
population results may have been different. (Wade et al., 2011). 
Research by Copeland et al. (2010) found the benefits of using telephone 
interventions in managing HF. The purpose of the study was to assess if telephone 
intervention improved quality of life and outcomes in patients with CHF. Participants 
came from the Veteran’s Administration (VA). The study used 458 participants in a 
quantitative randomized trial. The study had one year of pre-intervention, one year of 
intervention, and a follow-up period.  Data was collected using patient self-reports, 
instructor interviews, patient electronic records, and data extraction from the VA 
Resource Allocation Center for cost estimates. Patients in the study had access to a 
round-the-clock nurse advice line, medication reminders, action plans, literature, and 
motivational interviewing sessions. The study concluded no actual survivor benefit but it 
did provide behavioral improvements for those diagnosed HF.  The study lacked 
information regarding the impact of telephone monitoring has on readmissions (Copeland 
et al., 2010) 
The previous studies show little improvement in mortality and morbidity with HF. 
The studies do conclude better quality of life, decreased hospitalization and disease 
management when utilizing tele-monitoring. Possibly providing more aggressive 
interventions and tele-monitoring early in the HF disease process would improve 
outcomes.  Researchers in the study concluded short time frames and small population 
samples are possible reasons for little to no improvements on mortality. 
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Outpatient Clinic Research 
Outpatient clinics are one of the main outlets for providing HF monitoring across 
the healthcare continuum. The use of outpatient services is vital after a patient has been 
hospitalized with HF. Outpatient clinics provide patient with the care they need to avoid 
unnecessary hospitalizations.   
Research by Proctor et al. (2000) suggests that discharge planning decreases cost 
by increasing quality of care and prevention of early readmission. The study specifically 
looks at home care and its relationship with readmission rates among Medicare patients at 
an unidentified hospital.  The study used a prospective design to track Medicare patients 
with HF after their discharge. The sample included 253 Medicare patients that were ages 
65 and older. The study had a quantitative design that gathered data from a structured 
telephone interviews. The interviews were conducted at 6 weeks, 10 weeks, and 14 weeks 
post discharge. The study found that CHF patients most likely to be readmitted were 
sicker, noncompliant and, received less than adequate home care. The study suggests 
more research needs to be done in the home setting rather then while the patient is still 
institutionalized. This study was beneficial and it can used to identify and target 
individuals who are most likely to be readmitted in the weeks post discharge (Proctor et 
al. 2000). 
A study by Muss et al. (2010) looked at Veteran Affairs (VA) in a rural area to 
determine what impact outpatient visits have on hospital readmissions. The purpose of 
the study was to identify and compare potentially preventable readmissions with usage of 
30 day post discharge services. The study used logistic regression to examine post acute 
service use and its impact on readmission rates. Data from the VA from 2005 until 2007 
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was analyzed to examine patient characteristics and hospital admission rates among 
veterans. Data from the  sample was collected, categorize, and group using the 3M 
Potentially Preventable Readmissions (PPR) software. The PPR software identifies 
readmission are that result from deficiencies in care or treatment as opposed to unrelated 
events. Any related admissions that occurred within 30 days subsequent to an admission 
were identified as a PPR.  The quantitative study concluded that post follow-up care is an 
important factor to promote recovery and good health among hospitalized individuals 
with heart failure. (Muss et al., 2010). 
Research by Freimark et al. (2009) looked at data over five years at a CHF 
daycare clinic. Data was reviewed retrospectively on all patients admitted to that Medical 
Center CHF daycare between September 2000 and September 2005. The sample included 
190 advanced CHF patients. Information for the study was gathered by reviewing the 
computerized medical records of patients participating in the CHF daycare. Data included 
in the study was mortality, disease exacerbation, hospitalizations, and/or significant 
changes in patient condition. The study concluded that it is beneficial to provide CHF 
patients with outpatient services. Outpatient services provided in the study include 
multidrug intravenous treatment, electrolyte monitoring, cardiac rhythm monitoring, 
patient education, psychological support, and monitoring of cardiac rhythm. This study 
showed a reduction in morbidity and mortality and hospitalization were deceased during 
the time of the study.  (Freimark et al., 2009) 
The previous mentioned studies concluded that outpatient care plays a key role in 
decreasing readmissions rates. It is also beneficial to identify those who are at high risk 
for hospital readmission. Those at the highest rated for readmissions need to be targeted 
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and monitored closely across the health care continuum. All patients need to be 
monitored by a multidisciplinary team; those who are at high risk for admissions need to 
be given priority and more aggressive care in the outpatient setting.   
End of Life Care Research 
Research conducted by Haydar et al. (2004) incorporated interdisciplinary weekly 
meetings to assure care coordination in end of life CHF and dementia patients. The study 
was a retrospective case controlled study that took placed in a geriatrician led 
interdisciplinary house call program.  Patients were homebound and died under the care 
of the house call program from October 1996 to April 2001. The study sample was 142 
patients with a diagnosis of CHF or dementia.  Medical records where reviewed to obtain 
patient demographic, measure of function status, hospitalizations, and death place. The 
study determined that patients with CHF were more likely to have care plans directed at 
disease modification and treatments.  According to research, patients with CHF who die 
in the hospital create twice the expense as those who die elsewhere.  (Haydar et al., 
2004). 
A research study by Seamark et al. (2002) explored the prevalence of 
symptomatic HF in order to adopt a palliative care approach.  The study was city based in 
a market town with a rural catchment area.  Participants where selected through hand 
searching which yielded 548 patients with symptomatic HF.  The study was able to 
demonstrate a pragmatic method to estimate the prevalence of HF through utilization of 
diagnostic testing such as BNP levels. Although the death rate in the cohort was lower 
than expected the study was able to develop a palliative care approach in participants who 
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die not experience sudden death.  The study suggests further studies to identify HF 
patients with dying trajectory. (Seamark et al., 2002). 
Research by Gott et al. (2007) explored dying trajectories in HF.  The study used 
a quantitative longitudinal design.  The sample had a total of 27 participated who were 
diagnosed with HF, 60 years or older who had completed questionnaires for a minimum 
of five specific time points prior to death.  The study used the Kansas City 
Cardiomyopathy Questionnaire Physical Limitation Score.  From the data collected 
researchers in this study where unable to identify a typical dying trajectory.  The 
researcher suggests their findings challenge efforts to plan a deliver palliative care based 
on a theoretical HF death trajectory. (Gott et al., 2007) 
Boyd et al., (2009) evaluated services available for people with advanced HF and 
end of life care in the United Kingdom.  The studied used longitudinal analysis of 
interview triads in addition with cross-sectional analysis of interviews at specific stages.  
Researchers were able to gain access to patient and family experiences as treatments and 
services were discussed.  Recruitment for the study wad done through a purposeful 
sampling of individuals with NYHA Class III or IV HF. Data was collected through 
serial qualities interviews with participants and their families. The study led to the 
development of a HF care framework with varying stages.  The study concluded that 
patients with long-term conditions needing palliative care should be identified and 
managed proactively using pragmatic criteria.  (Boyd et al., 2009) 
Research by Gott et al. (2007) supports that of Seamark et al. (2002) in that dying 
trajectories are not always predictable.   The research suggests proactive approaches to 
managing dying trajectories.  
 21 
Psychosocial Implications 
The Worcester Heart Failure Study conducted by Saczynski et al., (2009) used a 
life table analysis to examine the difference in long term survival in relation to age. The 
study examined age specific differences in clinical presentation, receipt of therapy, 
recommended lifestyle modification and survival in hospitalized patients with acute heart 
failure. The study was a qualitative population based study conducted in a large Central 
New England metropolitan hospital.  The study had 4534 patients and conducted 
observational research between 1995 and 2000. Medical records were reviewed for 
demographic, clinical and treatment data.  Research participants were divided in four age 
groups; below age 65, ages 65-74, ages 74-84 and above 85. The study concluded that 
patients age 75 and older were mostly likely female, with multiple comorbidities, lower 
body mass index and higher ejection fractions. The study also concluded that older 
patients were more likely to receive symptom modifying medication as apposed to 
disease modifying treatments. The study contributes great knowledge to research in that 
older patient respect a distinct clinical presentation. (Saczynski et al., 2009). 
A research study by Dejong et al. (2005) supports the importance of assessing and 
treating patients with psychosocial parameters.  The purpose of the study was to consider 
the impact of sociodemographic, clinical, health perception and, emotional variables in 
predicting health status. The study tested a multivariable model of health status and was a 
sub study of a prospective, randomized clinical trail designed to determine the optimal 
disease management regimen to improve outcomes in HF patients. The study used 87 
participants to conceptualize health related quality of life, physical activity level and 
burden of symptoms. The study was conducted in three urban and suburban community 
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hospitals located in the Midwest. Participants for the study were recruited at the end of a 
HF hospitalization. The study used the Minnesota Living with Heart Failure 
Questionnaire in order to conceptualized symptoms. Questionnaires where administered 
within one week of discharge by a nurse research assistant.  Findings of the study 
concludes that clinicians who want to deliver patient center care must address 
sociodemographic and clinical measures to improve outcomes.  In addition to assessing 
these variables providers need to offer intervention to correct issues. (Dejong et al., 2005) 
In order to provide adequate patient care providers need to consider every factor 
in the treatment and diagnosis process.  Both age and social demographic play roles in 
how the HF patient is able to adapt to treatment.  Patient centered care is necessary across 
the healthcare continuum in order to improve outcomes. 
Conducting Chart Audits 
Maddocks et al. (2010) conducted a study to determine the feasibility of using 
electronic medical record (EMR) data from the Deliver Primary Healthcare Information 
(DELPHI) database.  Data was extracted in order to measure quality of care in patients 
with HF in ten primary healthcare practices in southwestern Ontario.  Researchers 
extracted data from the medical records of 488 patients who have CHF marked in the 
medical record over a period of three years. The study showed low frequencies of 
documented care items for CHF. In order to avoid errors made in the Maddocks et 
al.,(2010) study researchers should be mindful of obstacles such as incomplete patient 
records, inaccessibility of data and, reliability of EMR versus manual chart audits. 
Assiri (2011) conducted a qualitative retrospective cohort to investigate the 
clinical and therapeutic profiles of HF patients admitted to a Saudi Arabia Hospital.  The 
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study sample included 300 consecutive patients admitted to Aseer Central Hospital with a 
diagnosis of HF from June 2007 until May 2009.  Patient related data was analyzed 
utilizing frequencies, percentages, and measures of central tendencies. Results form the 
study support the concept of demonstrating trends in medical data. The study concluded 
making such data widely available will aid in the improvement of HF management and 
encourage providers to use evidence base guidelines in daily practice. 
Sanborn et al. (2005) used data from a chart audit to determine if CHF was the 
second leading cause of hospitalization in a small rural hospital. The study found that the 
majority of the patient population were older and noncompliant to prescribed medical 
regime.  The study used a chart abstraction tool to examine the care of all CHF patients 
admitted to the facility between 2000 and 2001.  The tool provided researchers with other 
information including sociodemographic status and outpatient appointment schedule.  
The study concluded CHF management in the rural area needed improvement. The study 
prompted attention to address the lack in continuity of care, outpatient services and 
access to diagnostic testing. 
The studies in this section all conclude that chart audits are valuable tools in 
obtaining data about a specific population.  When conducting chart audits researcher 
must be careful and make sure they get the whole picture so that the data is not 
misinterpreted. 
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Chapter Three 
 Methodology 
The purpose of this study is to evaluate the effects of monitoring congestive heart 
failure across the healthcare continuum with application to the Corbin and Strauss 
trajectory model of chronic illness.  This chapter describes the methodology used in the 
study including research design, sample, data collection, and data analysis.  
Procedures 
Initial approval for the study to evaluate the effects of monitoring congestive heart 
failure across the healthcare continuum on patient readmission with 30 days or less was 
obtained from the CHF Coordinator at the site where the research was conducted.  The 
following people at the site were notified of the study: The Director of Nursing for 
Cardiovascular Services, The Director of Nursing Research and the Nursing Research 
Council. The study is a retrospective chart review that used electronic medical record 
data queries to identify a sample of 100 admission cases.  
Ethical Considerations 
Prior to data collection the research study to evaluate the effects of monitoring 
congestive heart failure across the healthcare continuum on patient readmission with 30 
days or less was approved by the Institutional Research Board at Gardner-Webb 
University and by the Research Board at the study hospital. The study hospital follows 
the guidelines for patient confidentiality mandated by the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA). Confidentiality was maintained at all times 
and anonymity was insured. All account numbers, medical record numbers, and subject 
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names were omitted from the data queries. The individual records were labeled as a1 
through a100. 
Sample 
This study was conducted at a large medical university hospital. The CHF 
Coordinator of the research site has data on subjects with readmissions from the years 
2006 till present. Research subjects were admitted to an adult inpatient unit at the 
research site with an ICD-9 diagnosis relating to HF. The sample size includes a random 
selection of 100 consecutive CHF admission occurrences from the available data. 
Instruments 
A medical record audit for was used to collect data for the study. Validity of the 
audit form is evident by integrating concepts from Duke University Medical Center’s 
Department of Community and Family Medicine in its development (2005).  Variables 
addressed in the audits include, financial glass group, thirty day readmission occurrences, 
and discharge dispositions (Appendix C).  
Data Collection and Analysis 
Data queries where conducted on patients with heart failure ICD-9 codes.  
Retrospective data was reviewed from the dates of November 2009 until and May 2010.  
Data included in the review were admission dates, discharge dates, readmission dates if 
applicable, disposition and, financial class.  
Each of one of the 100 admission cases was applied to the chart audit form.  Data 
from the chart audits where compiled into corresponding groups. Occurrences and trends 
were identified.  A chi-square test was used to show the likelihood of readmission 
occurring without the intervention of monitoring across the healthcare continuum. 
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Chapter 4 
 Results 
This chapter presents the results of the study to evaluate the effects of monitoring 
CHF across the healthcare continuum.  The sample demographics are presented, followed 
by the results for the research questions. One hundred consecutive CHF admissions were 
randomly selected for the research study. A chi-square analysis of the research data was 
conducted on the patient data related to the 100 different admission occurrences. 
Demographical data collected in the study shows the financial classification 
regarding pay for services for the sample population.  The majority of subjects (79%) of 
the sample were Medicare Beneficiaries, with 10% charity cases, 7% managed care and 
only 1% private insurance.  The financial classifications regarding pay for services for the 
sample is illustrated in Figure 2.  With such a large Medicare patient population it is 
essential that care is managed correctly. According to the Unites States Department of 
Health and Human Service, Medicare will pay for inpatient acute care services based on 
care quality and not the quantity (USDA, 2011).  Research suggests patients that continue 
to get readmitted have received inadequate care somewhere in their disease management 
process. 
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Figure 2 
Financial Class Percentages 
 
 
 
 
 
 
 
 
Research has shown that readmissions are where quality, cost, and patient safety 
intersect (Brock, 2008).  Descriptive statistical analysis of the data found that a large 
portion (n =29) of the sample was readmitted in 30 days or less following discharge.  
Figure 3 illustrates the readmission rates for the sample.   
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Further breakdown of the data found over half (n =52 ) of the sample population 
was readmitted within 90 days following discharge.  Less than 20 CHF patients remained 
out of the hospitalized for a minimum of 180 days. 
Figure 4 
Readmission Rates Breakdown 
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Statistical analysis utilizing the chi-squared test was conducted to test the 
hypothesis that monitoring CHF across the healthcare continuum effects CHF 
readmission rates.  The dependent variables in the study were readmission in 30 days or 
less and no readmission in 30 days or less. The chi-squared test is used to determine how 
well observed data fits anticipated outcomes.  In this study a chi-squared test was used to 
determine the difference between the observed outcome of readmission in 30 days or less 
and the outcome that the readmission in 30 days or less was likely to occur by chance.  
The study compares what would have occurred in the absence of any true association 
between healthcare given across the continuum and ≤30 day readmission rates.  
If there is no relationship between care across the continuum and readmission in 
30 days or less it would be expected that a patient would be readmitted solely by chance. 
The null hypothesis for this study was there is no relationship between care across the 
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continuum and readmission in 30 days or less for patients with CHF. The statistical level 
of significance was set at .05. Results of the chi-squared test (p=0.7276) indicated the 
results were not significant and the null hypothesis could not be rejected. The data used in 
the study was unable to establish that health care across the continuum has an effect on 
CHF patients being readmitted to the hospital in 30 days or less.  Table 4 shows the result 
of the Chi-Squared Test for Heart Failure Readmission.  
Table 4. 
Chi-Squared Test: Heart Failure Readmissions 
Chi-Squared Test: Monitoring Healthcare Across the Continuum 
Observed Outcomes 
 
Readmitted ≤30 
Days Not Readmitted in ≤30 Days 
Row 
Total
s 
Continuum Services Utilized 14 37 51 
Continuum Services Not Utilized 15 34 49 
Column Totals 29 71 100 
    
    
Expected Outcomes 
 
Readmitted ≤30 
Days Not Readmitted in ≤30 Days 
Row 
Total
s 
Continuum Services Utilized 14.79 36.21 51 
Continuum Services Not Utilized 14.21 34.79 49 
Column Totals 29 71 100 
    
    
p=value: 0.727637589   
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Chapter Five 
Discussion 
Significance of the Findings 
The chi-squared analysis of the data did not support the hypothesis that health 
care across the continuum has an effect on CHF patients being readmitted to the hospital 
in 30 days or less. The null hypothesis could not be rejected at the 0.05 level of 
significance. The research study does provide insight on healthcare and readmission rates 
for the CHF population. The Corbin and Strauss trajectory model for chronic illness was 
suitable in the study due to the large portion of readmission occurrences for patients with 
CHF. The patients with CHF who were subjects in this study cycled and repeated phases 
in the model. Although results from the study are that readmissions occurred by chance 
and not as a result of healthcare across the continuum, it was evident that a large portion 
of the sample was readmitted in 90 days or less.   
Significance to Nursing 
There are many nursing implications to consider when dealing with the CHF 
patient.  According to Brock (2008) a quarter of all patients hospitalized with CHF are 
readmitted within 30 days.  Proper patient education, compliance promotion, and 
transition care are beneficial to patient outcomes and readmission rates. 
According to Brock (2008) 20% of Medicare beneficiaries are readmitted within 
30 days.  Brock (2008) further states the high level of readmission indicates inappropriate 
transition care, lower patient satisfaction, and increased health care cost. The high 
number of Medicare patients in this sample and the high number of readmissions calls for 
specific interventions aimed at this population of healthcare recipients. 
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There are many implications for nurses when dealing with the HF patients.  
Equipping patient with medication, scales, and blood pressure cuffs is not enough. A 
patient that monitors and medicates themselves inappropriately is an insignificant act that 
provides no benefit to the patient. According to Brock (2008) patients need to have scales 
big enough to stand on and have numbers that are visible to the patient. Missing any key 
component in the medical regime is s sign of inadequate care coordination, mismanaged 
self-care and, can lead to an unnecessary hospitalization. (Brock, 2008). The high number 
of readmissions revealed in the data analysis calls for stronger medical regime and 
management of CHF patients over the continuum of healthcare. 
In addition to patient accountably there must be accountability among providers.  
The Medicare Payment Advisory Commission states that readmissions are not a result of 
mistakes that occur in the hospital by inadequate transition preparation (Hackbarth, 
2009).  According to Brock (2008) one in five patients discharged from a hospital 
experience an adverse event within three weeks of being discharged. Injuries resulting 
from these adverse events are medicine related and often can be mitigated or avoided.  
Implications for Nursing Practice 
The study uncovered a large number of readmissions that occurred 30 days or less 
from discharge.  For nursing this is a travesty that demonstrates inadequate healthcare 
over the continuum. Nurses can be a proponent of these patients through more effective 
discharge planning, community follow up and referrals for CHF patients. Adequate 
intervention could have deferred and possibly avoided these readmissions. 
The number of readmissions also has an effect on reimbursement of services.  The 
number of charity patients in the study sample calls for decreasing readmissions. The 
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smallest percentage of decrease in hospital readmissions has the potential to decrease 
healthcare costs for all.  
Recommendations for future research 
The sample selection only included a small portion of CHF admission 
occurrences.  Future research should include a larger sample size from multiple 
healthcare facilities.  Conducting a more comprehensive analysis of discharge disposition 
could provide more insight on what continuum services are most effective. Identification 
of the relationship of financial classification regarding pay for services on readmission 
rates should be included in future research.  In order to improve outcomes and 
reimbursement, the healthcare team should analyzes which needs of the CHF patients are 
continuing to be left unmet. 
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 Appendix B 
Medical Record Audit Instrument Developed for Study 
Date: 
Auditor: 
Admission dates included in study: 
Total Medical Records Reviewed: 
Subjects included in the audit:  
 
Financial Class Group Yes or No (Binary, only one applicable) 
Charity  
Managed Care  
Medicaid  
Medicare  
Private Insurance  
Other  
 
Discharge Status Yes or No (Binary, only one applicable) 
AMA  
Home w/o continuum services  
Home w/ CHF Clinic Visit  
Home Health  
Hospice  
SNF  
Rehab  
 
Thirty Day Readmission Occurrences Yes or No (Binary, only one applicable) 
≤30 Days  
>30 Days  
 
Readmission Occurrence Breakdown Yes or No (Binary, only one applicable) 
<30 Days  
30-59 Days  
60-89 Days  
90-119 Days  
120-149 Days  
150-179 Days  
 
